Abstract
In a controlled study (the control group receiving pyribenzamine) it was observed that reserpine, in the dosage used, had no effect on weight loss in patients receiving d-amphetamine sulphate (Dexedrine®) and methyl cellulose (Cellothyl®) while on 1,000-calorie diets as compared with the control group.
There was no observable difference in subjective feelings of the patients in the two groups.
Reserpine had no effect on the length of time the patients remained on their diets.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HUGHES W., DENNIS E., McCONN R., FORD R., MOYER J. H. Reserpine (serpasil) in the treatment of hypertension. Am J Med Sci. 1954 Jul;228(1):21–35. doi: 10.1097/00000441-195407000-00003. [DOI] [PubMed] [Google Scholar]
- JONAS A. D. A psychobiologic approach to the problem of obesity. Am Pract Dig Treat. 1950 Sep;1(9):933–937. [PubMed] [Google Scholar]
- KINARD S., MILLS L. C., MOYER J. H., TERRELL J. Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy. J Am Geriatr Soc. 1956 Nov;4(11):1073–1077. doi: 10.1111/j.1532-5415.1956.tb01039.x. [DOI] [PubMed] [Google Scholar]
- MCNAIR J. D. A new drug in the management of obesity; a preliminary report. Am Pract Dig Treat. 1955 Nov;6(11):1652–1653. [PubMed] [Google Scholar]
- NECHELES H., SORTER H. Balanced amphetamine and sedative combination in the treatment of obesity. J Lancet. 1957 Jun;77(6):215–216. [PubMed] [Google Scholar]
- PROUET P. E. Rauwolfia and amphetamine therapy in the treatment of psychosomatic complaints. J La State Med Soc. 1955 Mar;107(3):114–116. [PubMed] [Google Scholar]
- TRINITY G. J. Management of the depressed patient. Med Times. 1954 Oct;82(10):753–757. [PubMed] [Google Scholar]